NatrixLab Chooses SurgiLance Safety Lancet for Capillary Fingerstick Solution
Fingerstick Device's Ease of Use, Safety and Price Among Key Factors.
Reggio Emilia, Italy, February 28, 2012 --(PR.com)-- MediPurpose(r), a master medical product distributor and manufacturer, today announced a new customer relationship with NatrixLab SRL, an Italian clinical laboratory and innovator within the area of diagnostic tests used in optimizing health and wellness.
NatrixLab will include the SurgiLance(r) safety lancets in its capillary blood test kits.
NatrixLab specializes in bloodstream testing and analysis of nutritional anomalies that can lead to cellular degeneration and disease within the human body. Currently, NatrixLab offers tests that measure food intolerance, cellular aging and lipid profiles, among others.
According to NatrixLab General Manager Mario Brevini, both quality and cost effectiveness were critical factors in his choice to integrate SurgiLance safety lancets.
"The SurgiLance safety lancet is easy to use and safe," said Brevini. "I was looking for a handy and practical lancet, and MediPurpose gave me the best product at the most competitive price."
Its new relationship with NatrixLab represents the first point-of-care alliance for MediPurpose in Italy. However, the medical device manufacturer's blood collection products have already received a warm reception in the country. SurgiLance safety lancets, along with the babyLance(r) infant heel incision device, were introduced to the Italian market last summer by international distributor Haemoclub SRL.
Demand for both devices is expected to grow, following the tightening of international standards mandating the adoption of single-use sharps devices, according to MediPurpose founder and CEO Patrick Yi.
SurgiLance is currently available in six models, ranging from 18-26 gauges and 1.0-2.3 mm penetration depths. Valued for its safety, comfort and ease of use, the SurgiLance safety lancet is one of the top selling fingerstick devices in the United States and is available to healthcare professionals through a broad network of distributors, both in the United States and globally.
For more information about SurgiLance safety lancets, including no-cost product sample requests, please visit http://www.medipurpose.com/surgilance.
About NatrixLab
NatrixLab SRL is an authorized analysis laboratory founded in Reggio Emilia, Italy in 2000.
From its inception, it has dealt with diagnostics and the development of the innovative Food Intolerance Test to detect adverse reactions to foods containing IgG class antibodies. Today, with more than 140,000 case reports, it boasts the most authoritative available database on the phenomenon.
NatrixLab meets its customers' needs through the development of innovative tests applied to different interventive areas. The result of natural evolution in technology and knowledge in the field of diagnostics and nutrition, these tests form the basis of a partnership with its clients that has persistently grown ever more intimate and specialized over the years.
For more information about NatrixLab, please visit http://www.natrix.it.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(r) heel incision device, SurgiLance(r) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com.
###
NatrixLab will include the SurgiLance(r) safety lancets in its capillary blood test kits.
NatrixLab specializes in bloodstream testing and analysis of nutritional anomalies that can lead to cellular degeneration and disease within the human body. Currently, NatrixLab offers tests that measure food intolerance, cellular aging and lipid profiles, among others.
According to NatrixLab General Manager Mario Brevini, both quality and cost effectiveness were critical factors in his choice to integrate SurgiLance safety lancets.
"The SurgiLance safety lancet is easy to use and safe," said Brevini. "I was looking for a handy and practical lancet, and MediPurpose gave me the best product at the most competitive price."
Its new relationship with NatrixLab represents the first point-of-care alliance for MediPurpose in Italy. However, the medical device manufacturer's blood collection products have already received a warm reception in the country. SurgiLance safety lancets, along with the babyLance(r) infant heel incision device, were introduced to the Italian market last summer by international distributor Haemoclub SRL.
Demand for both devices is expected to grow, following the tightening of international standards mandating the adoption of single-use sharps devices, according to MediPurpose founder and CEO Patrick Yi.
SurgiLance is currently available in six models, ranging from 18-26 gauges and 1.0-2.3 mm penetration depths. Valued for its safety, comfort and ease of use, the SurgiLance safety lancet is one of the top selling fingerstick devices in the United States and is available to healthcare professionals through a broad network of distributors, both in the United States and globally.
For more information about SurgiLance safety lancets, including no-cost product sample requests, please visit http://www.medipurpose.com/surgilance.
About NatrixLab
NatrixLab SRL is an authorized analysis laboratory founded in Reggio Emilia, Italy in 2000.
From its inception, it has dealt with diagnostics and the development of the innovative Food Intolerance Test to detect adverse reactions to foods containing IgG class antibodies. Today, with more than 140,000 case reports, it boasts the most authoritative available database on the phenomenon.
NatrixLab meets its customers' needs through the development of innovative tests applied to different interventive areas. The result of natural evolution in technology and knowledge in the field of diagnostics and nutrition, these tests form the basis of a partnership with its clients that has persistently grown ever more intimate and specialized over the years.
For more information about NatrixLab, please visit http://www.natrix.it.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(r) heel incision device, SurgiLance(r) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com.
###
Contact
MediPurpose
Derek Rudnak
888-808-6494
www.medipurpose.com
Derek Rudnak
888-808-6494
www.medipurpose.com
Contact
Categories